Ultravist 300 and Dyspnea - a phase IV clinical study of FDA data

Summary:

Dyspnea is reported as a side effect among people who take Ultravist 300 (iopromide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lisinopril, and have Computerised tomogram abdomen.

The phase IV clinical study analyzes which people have Dyspnea when taking Ultravist 300. It is created by eHealthMe based on reports of 2,780 people who have side effects when taking Ultravist 300 from the FDA, and is updated regularly.

What is Ultravist 300?

Ultravist 300 has active ingredients of iopromide. eHealthMe is studying from 2,781 Ultravist 300 users. Check the latest studies of Ultravist 300.

What is Dyspnea?

Dyspnea (difficult or laboured breathing) is found to be associated with 3,715 drugs and 6,067 conditions by eHealthMe. Check the latest studies of Dyspnea.

On Jul, 20, 2026

2,780 people reported to have side effects when taking Ultravist 300.
Among them, 390 people (14.03%) have Dyspnea.

Among these 390 people:

* Approximation only. Some reports may have incomplete information.

Do you take Ultravist 300 and have Dyspnea?

- Check whether Dyspnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ultravist 300:

Ultravist 300 (2,781 reports)

Dyspnea treatments and more:

Dyspnea (661,578 reports)

How severe was Dyspnea and when was it recovered:

Dyspnea in Ultravist 300

Expand to all the drugs that have ingredients of iopromide:

Dyspnea and drugs with ingredients of iopromide (1,310 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ultravist 300:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea:

Dyspnea (3,715 drugs)

Browse all the conditions that are associated with Dyspnea:

Dyspnea (6,067 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on iopromide (the active ingredients of Ultravist 300) and Ultravist 300 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.